½ÃÀ庸°í¼­
»óǰÄÚµå
1508445

Å©·Î³ëÅ×¶óÇÇ ¼­ºñ½º ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2034³â)

Chronotherapy Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Transparency Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 134 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Å©·Î³ëÅ×¶óÇÇ ¼­ºñ½º ½ÃÀå - Á¶»ç ¹üÀ§

TMRÀÇ Á¶»ç º¸°í¼­ "¼¼°èÀÇ Å©·Î³ëÅ×¶óÇÇ ¼­ºñ½º ½ÃÀå"Àº 2024³âºÎÅÍ 2034³â±îÁöÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ÁöÇ¥¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» ¾ò±â À§ÇØ °ú°Å»Ó¸¸ ¾Æ´Ï¶ó ÇöÀçÀÇ ¼ºÀå µ¿Çâ°ú ±âȸ¸¦ Á¶»çÇß½À´Ï´Ù. ÀÌ º¸°í¼­´Â 2024³âÀ» ±âÁØ¿¬µµ·Î, 2034³âÀ» ¿¹Ãø ¿¬µµ·Î ÇÏ¿© 2018³âºÎÅÍ 2034³â±îÁöÀÇ ¼¼°è Å©·Î³ëÅ×¶óÇÇ ¼­ºñ½º ½ÃÀåÀÇ ¼öÀͰú ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ 2024³âºÎÅÍ 2034³â±îÁö ¼¼°è Å©·Î³ëÅ×¶óÇÇ ¼­ºñ½º ½ÃÀåÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR%)µµ Á¦½ÃÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ±¤¹üÀ§ÇÑ 1Â÷ Á¶»ç, KOL(Key Opinion Leader), ¾÷°è ¸®´õ ¹× ¿ÀÇǴϾð Á¦Á¶¾÷ü¿ÍÀÇ ÀÎÅͺä, ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° ÀÚ·á, ¿¬·Ê º¸°í¼­, º¸µµ ÀÚ·á, °ü·Ã ÀÚ·á µîÀ» ÂüÁ¶ÇÑ 2Â÷ Á¶»ç, ±×¸®°í Å©·Î³ëÅ×¶óÇÇ ¼­ºñ½º ½ÃÀåÀ» ÀÌÇØÇϱâ À§ÇØ ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° ÀÚ·á, ¿¬·Ê º¸°í¼­, º¸µµ ÀÚ·á ¹× °ü·Ã ÀڷḦ ÂüÁ¶ÇÏ¿© ÀÛ¼ºµÇ¾ú½À´Ï´Ù.

½ÃÀå ÇöȲ
2023³â ½ÃÀå ±Ô¸ð 8¾ï 2,270¸¸ ´Þ·¯
2034³â ½ÃÀå ±Ô¸ð 13¾ï ´Þ·¯
CAGR 4.3%

ÀÌ º¸°í¼­´Â ¼¼°è Å©·Î³ëÅ×¶óÇÇ ¼­ºñ½º ½ÃÀåÀÇ °æÀï ȯ°æÀ» Á¶»çÇß½À´Ï´Ù. ¼¼°è Å©·Î³ëÅ×¶óÇÇ ¼­ºñ½º ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷µéÀÌ È®ÀεǾúÀ¸¸ç, °¢ ±â¾÷µéÀº ´Ù¾çÇÑ ¼Ó¼ºÀ¸·Î ÇÁ·ÎÆÄÀϸµµÇ¾î ÀÖ½À´Ï´Ù. ±â¾÷ °³¿ä, À繫 »óÅÂ, ÃÖ±Ù µ¿Çâ, SWOT µîÀº ÀÌ º¸°í¼­¿¡¼­ ¼Ò°³ÇÏ´Â ¼¼°è Å©·Î³ëÅ×¶óÇÇ ¼­ºñ½º ½ÃÀå ±â¾÷ÀÇ ¼Ó¼ºÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÀüÁ¦Á¶°Ç°ú Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à : ½ÃÀå

Á¦4Àå ½ÃÀå °³¿ä

  • ¼­·Ð
  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ºÐ¼®°ú ¿¹Ãø, 2020-2034³â

Á¦5Àå ÁÖ¿ä ÀλçÀÌÆ®

  • ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®
  • ÁÖ¿ä ¾à¹° Ŭ·¡½º/ºê·£µå ºÐ¼®
  • ÁÖ¿ä M&A
  • COVID-19ÀÇ »ê¾÷¿¡ ´ëÇÑ ¿µÇâ

Á¦6Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Á¦Ç° À¯Çüº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú¿Í ¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : Á¦Ç° À¯Çüº°, 2020-2034³â
    • Å©·Î³ëÅ×¶óÇÇ ½Ã½ºÅÛ
    • Å©·Î³ëÅ×¶óÇÇ ÀǾàǰ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç° À¯Çüº°

Á¦7Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Ä¡·á ¿µ¿ªº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú¿Í ¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : Ä¡·á ¿µ¿ªº°, 2020-2034³â
    • Á¾¾çÇÐ
    • ½Å°æÇÐ
    • ½ÉÇ÷°üÁúȯ
    • È£Èí±âÁúȯ
    • ±âŸ(ÇǺΰú µî)
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Ä¡·á ¿µ¿ªº°

Á¦8Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú¿Í ¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2020-2034³â
    • º´¿ø ¹× Ŭ¸®´Ð
    • °¡Á¤Ä¡·á ȯ°æ
    • ±âŸ(¿¬±¸±â°ü µî)
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : Áö¿ªº°, 2020-2034³â
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦10Àå ºÏ¹Ì ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦11Àå À¯·´ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦13Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦14Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±â¾÷ - °æÀï ¸ÅÆ®¸¯½º(±â¾÷ Tier ¹× ±Ô¸ðº°)
  • ½ÃÀå Á¡À¯À² ºÐ¼® : ±â¾÷º°(2023³â)
  • ±â¾÷ °³¿ä
    • Koninklijke Philips N.V.
    • Vyaire Medical
    • Verilux, Inc.
    • Zepter International
    • Medtronic plc
    • Teva Pharmaceutical Industries Ltd.
LSH 24.07.11

Chronotherapy Services Market - Scope of Report

TMR's report on the global chronotherapy services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global chronotherapy services market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global chronotherapy services market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the chronotherapy services market.

Market Snapshot
Market Value in 2023US$ 822.7 Mn
Market Value in 2034US$ 1.3 Bn
CAGR4.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global chronotherapy services market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global chronotherapy services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global chronotherapy services market.

The report delves into the competitive landscape of the global chronotherapy services market. Key players operating in the global chronotherapy services market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global chronotherapy services market profiled in this report.

Key Questions Answered in Global chronotherapy services Market Report:

  • What is the sales/revenue generated by chronotherapy services across all regions during the forecast period?
  • What are the opportunities in the global chronotherapy services market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Chronotherapy Services Market - Research Objectives and Research Approach

The comprehensive report on the global chronotherapy services market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global chronotherapy services market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global chronotherapy services market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Chronotherapy Services Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Drug Class Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Chronotherapy Services Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Drug Class /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Chronotherapy Services Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2020-2034
    • 6.3.1. Chronotherapy System
    • 6.3.2. Chronotherapy Drugs
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Chronotherapy Services Market Analysis and Forecast, by Therapeutic Area

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Therapeutic Area, 2020-2034
    • 7.3.1. Oncology
    • 7.3.2. Neurology
    • 7.3.3. Cardiovascular Diseases
    • 7.3.4. Respiratory Diseases
    • 7.3.5. Others (Dermatology, etc.)
  • 7.4. Market Attractiveness Analysis, by Therapeutic Area

8. Global Chronotherapy Services Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2034
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. Homecare Settings
    • 8.3.3. Others (Research Institutes, etc.)
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Chronotherapy Services Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2034
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Chronotherapy Services Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Product Type, 2020-2034
    • 10.3.1. Chronotherapy System
    • 10.3.2. Chronotherapy Drugs
  • 10.4. Market Value Forecast, by Therapeutic Area, 2020-2034
    • 10.4.1. Oncology
    • 10.4.2. Neurology
    • 10.4.3. Cardiovascular Diseases
    • 10.4.4. Respiratory Diseases
    • 10.4.5. Others (Dermatology, etc.)
  • 10.5. Market Value Forecast, by End-user, 2020-2034
    • 10.5.1. Hospitals & Clinics
    • 10.5.2. Homecare Settings
    • 10.5.3. Others (Research Institutes, etc.)
  • 10.6. Market Value Forecast, by Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Product Type
    • 10.7.2. By Therapeutic Area
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Chronotherapy Services Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Product Type, 2020-2034
    • 11.3.1. Chronotherapy System
    • 11.3.2. Chronotherapy Drugs
  • 11.4. Market Value Forecast, by Therapeutic Area, 2020-2034
    • 11.4.1. Oncology
    • 11.4.2. Neurology
    • 11.4.3. Cardiovascular Diseases
    • 11.4.4. Respiratory Diseases
    • 11.4.5. Others (Dermatology, etc.)
  • 11.5. Market Value Forecast, by End-user, 2020-2034
    • 11.5.1. Hospitals & Clinics
    • 11.5.2. Homecare Settings
    • 11.5.3. Others (Research Institutes, etc.)
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Therapeutic Area
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Chronotherapy Services Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Product Type, 2020-2034
    • 12.3.1. Chronotherapy System
    • 12.3.2. Chronotherapy Drugs
  • 12.4. Market Value Forecast, by Therapeutic Area, 2020-2034
    • 12.4.1. Oncology
    • 12.4.2. Neurology
    • 12.4.3. Cardiovascular Diseases
    • 12.4.4. Respiratory Diseases
    • 12.4.5. Others (Dermatology, etc.)
  • 12.5. Market Value Forecast, by End-user, 2020-2034
    • 12.5.1. Hospitals & Clinics
    • 12.5.2. Homecare Settings
    • 12.5.3. Others (Research Institutes, etc.)
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Therapeutic Area
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Chronotherapy Services Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Product Type, 2020-2034
    • 13.3.1. Chronotherapy System
    • 13.3.2. Chronotherapy Drugs
  • 13.4. Market Value Forecast, by Therapeutic Area, 2020-2034
    • 13.4.1. Oncology
    • 13.4.2. Neurology
    • 13.4.3. Cardiovascular Diseases
    • 13.4.4. Respiratory Diseases
    • 13.4.5. Others (Dermatology, etc.)
  • 13.5. Market Value Forecast, by End-user, 2020-2034
    • 13.5.1. Hospitals & Clinics
    • 13.5.2. Homecare Settings
    • 13.5.3. Others (Research Institutes, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Therapeutic Area
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Chronotherapy Services Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Product Type, 2020-2034
    • 14.3.1. Chronotherapy System
    • 14.3.2. Chronotherapy Drugs
  • 14.4. Market Value Forecast, by Therapeutic Area, 2020-2034
    • 14.4.1. Oncology
    • 14.4.2. Neurology
    • 14.4.3. Cardiovascular Diseases
    • 14.4.4. Respiratory Diseases
    • 14.4.5. Others (Dermatology, etc.)
  • 14.5. Market Value Forecast, by End-user, 2020-2034
    • 14.5.1. Hospitals & Clinics
    • 14.5.2. Homecare Settings
    • 14.5.3. Others (Research Institutes, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Therapeutic Area
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Koninklijke Philips N.V.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Drug Class Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Vyaire Medical
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Drug Class Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Verilux, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Drug Class Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Zepter International
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Drug Class Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Medtronic plc
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Drug Class Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Teva Pharmaceutical Industries Ltd.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Drug Class Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦